Last close As at 05/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: Financials
OTC Markets Group’s (OTCM’s) Q122 net income was up 11% y-o-y despite weaker financial markets trading volume and prices. Corporate services (+51% y-o-y) and market data licensing (+9% y-o-y) revenue was as resilient as expected and compensated for the 47% decline in OTC Link revenue. However, operating expenses rose by 12% due to rising staff compensation and IT. OTCM purchased Blue Sky Data for $12m cash in May 2022, allowing OTCM to improve its value proposition and expand its subscriber base. We maintain our assumption that markets will remain choppy due to concerns about inflation and rising interest rates. We have cut our EPS forecasts for FY22 and FY23 by 19% and 17% respectively to reflect higher operating expense assumptions. We have cut our dividend forecasts by 20% but note that this could be conservative given OTCM’s strong balance sheet and cash flow generation.
Written by
OTC Markets Group |
Q122 – net income up 11%, but costs start to bite |
Q122 update |
Financial services |
30 May 2022 |
Share price performance
Business description
Next events
Analysts
OTC Markets Group is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||||
OTC Markets Group’s (OTCM’s) Q122 net income was up 11% y-o-y despite weaker financial markets trading volume and prices. Corporate services (+51% y-o-y) and market data licensing (+9% y-o-y) revenue was as resilient as expected and compensated for the 47% decline in OTC Link revenue. However, operating expenses rose by 12% due to rising staff compensation and IT. OTCM purchased Blue Sky Data for $12m cash in May 2022, allowing OTCM to improve its value proposition and expand its subscriber base. We maintain our assumption that markets will remain choppy due to concerns about inflation and rising interest rates. We have cut our EPS forecasts for FY22 and FY23 by 19% and 17% respectively to reflect higher operating expense assumptions. We have cut our dividend forecasts by 20% but note that this could be conservative given OTCM’s strong balance sheet and cash flow generation.
Year end |
Gross revenue ($m) |
PBT |
EPS* |
DPS** |
P/E |
Yield |
12/20 |
71.2 |
21.4 |
1.53 |
1.25 |
36.4 |
2.2 |
12/21 |
102.9 |
38.0 |
2.52 |
2.16 |
22.1 |
3.9 |
12/22e |
96.9 |
28.0 |
1.86 |
1.72 |
30.1 |
3.1 |
12/23e |
102.3 |
31.0 |
1.95 |
1.72 |
28.6 |
3.1 |
Note: *Fully diluted and calculated after restricted stock award allocation. **Including special dividends of 65c in FY20, $1.50 in FY21 and $1.00 in FY22e and FY23e.
Q122: Costs rose by 12%
Staff expenses rose by 14% y-o-y driven by higher wages and the number of staff rising by nine to 112, while IT expenditure rose by 20%. The rising costs reflect job market pressure, the need to invest for growth and compliance costs. We expect some one-off acquisition-related expenses in Q222. We have raised our forecast operating expenses for FY22 and FY23 by 22% and could make some adjustments following more guidance regarding Blue Sky Data.
Blue Sky Data acquisition
Blue Sky Data Corp provides equity and debt compliance data on state ‘blue sky’ securities rules and regulations. This will help subscribers better understand US compliance and state securities laws. The deal is expected to bring approximately 30 clients in addition to the synergies with the market data licensing business. OTCM had a net cash position of $45m (excluding restricted cash) at the end of Q122. OTCM aims to largely integrate Blue Sky Data by the end of June. A handful of employees are expected to be added to OTCM’s headcount.
Valuation: $42.7–64.4 per share, 3.1% yield
We have reduced our FY22 and FY23 EPS forecasts by 19% and 17% respectively. OTCM is trading on FY22e and FY23e P/E multiples of 30.1x and 28.6x respectively, a premium to our sample of peers. Our DCF-based valuation range is $42.7–64.4 per share (previously $42.4–66.3); we flex the cost of equity (7–11%) and the annual growth rate for 2026–32e (3–6%).
Q122 analysis
A summary of the quarterly progress in OTCM’s profit and loss figures is given in Exhibit 1. We highlight the key points below (the comparisons are year-on-year unless stated):
■
Gross revenue was $25.9m, flat year-on-year, -1% q-o-q. Lower trading volumes drove the significant 47% decline in OTC Link, which was nevertheless a little bit better than we expected (55% decline). The quarter-on-quarter decline was 3%. Corporate services rose by 51% driven by an increase in listed companies on the OTCQX and OTCQB and price increases, while market data licensing rose by 9%. It is noteworthy that both corporate services and market data licensing have remained relatively resilient during the market downturn: on a quarter-on-quarter basis the former rose by 1% and the latter declined only 2%. Exhibit 2 shows how the corporate client base for the OTCQX and OTCQB markets has evolved from Q120 and shows steady, good growth from Q320.
■
Transaction-based expenses (liquidity provider rebate payments) fell by 57%, reflecting the lower trading volumes, while redistribution fees (relating to Market Data Licensing) rose by 6%.
■
Net revenue less transaction-based expenses rose 8% to $23.6m (down 1% q-o-q).
■
Operating expenses (before depreciation and amortisation) increased by 12% mainly reflecting salary and headcount increases (see Exhibit 3 and discussion below for further details), as well as the expansion of the electronic trading system.
■
Profit before tax rose by 3% to $8.6m and was down 19% q-o-q due to the higher operating expenses and lower trading volumes. The effective tax rate was quite below the trend level at 12% and led to EPS increasing by 9%, although this was still down 16% quarter-on-quarter. As we discuss later, we assume a 22% rate going forward. The operating margin was 34.4% after the unusually high 42.4% in Q421.
■
A quarterly dividend of $0.18 was maintained.
Exhibit 1: Q122 results summary
$000s unless stated |
Q121 |
Q221 |
Q321 |
Q421 |
Q122 |
% change y-o-y |
% change q-o-q |
OTC Link |
10,282 |
7,682 |
6,110 |
5,591 |
5,433 |
(47) |
(3) |
Market Data Licensing |
7,899 |
8,586 |
8,489 |
8,777 |
8,583 |
9 |
(2) |
Corporate Services |
7,895 |
9,182 |
10,621 |
11,819 |
11,933 |
51 |
1 |
Gross revenues |
26,076 |
25,450 |
25,220 |
26,187 |
25,949 |
(0) |
(1) |
Redistribution fees and rebates |
(741) |
(746) |
(744) |
(790) |
(788) |
6 |
(0) |
Net revenue |
25,335 |
24,704 |
24,476 |
25,397 |
25,161 |
(1) |
(1) |
Transaction-based expenses |
(3,539) |
(2,487) |
(1,668) |
(1,578) |
(1,515) |
(57) |
(4) |
Revenues less transaction-based expenses |
21,796 |
22,217 |
22,808 |
23,819 |
23,646 |
8 |
(1) |
Operating expenses (excluding depreciation & amort.) |
(12,933) |
(12,633) |
(12,686) |
(12,576) |
(14,562) |
13 |
16 |
Depreciation and amortisation |
(444) |
(441) |
(446) |
(465) |
(440) |
(1) |
(5) |
Income from operations |
8,419 |
9,143 |
9,676 |
10,778 |
8,644 |
3 |
(20) |
Other income/net interest |
5 |
0 |
12 |
(68) |
0 |
||
Profit before tax |
8,424 |
9,143 |
9,688 |
10,710 |
8,644 |
3 |
(19) |
Taxes |
(1,586) |
(2,071) |
(2,176) |
(1,656) |
(1,030) |
(35) |
(38) |
Net income |
6,838 |
7,072 |
7,512 |
9,054 |
7,614 |
11 |
(16) |
Diluted EPS ($) |
0.57 |
0.59 |
0.62 |
0.74 |
0.62 |
9 |
(16) |
Operating margin on net revenue (%) |
33.2 |
37.0 |
39.5 |
42.4 |
34.4 |
||
Tax rate (%) |
18.8 |
22.7 |
22.5 |
15.5 |
11.9 |
Source: OTCM, Edison Investment Research
Exhibit 2: Evolution of OTCQX and OTCQB corporate client base
Q120 |
Q220 |
Q320 |
Q420 |
Q121 |
Q221 |
Q321 |
Q421 |
Q122 |
|
OTCQX |
|||||||||
Start |
442 |
414 |
415 |
441 |
461 |
482 |
530 |
561 |
570 |
Additions |
9 |
19 |
44 |
34 |
52 |
70 |
55 |
35 |
33 |
Other (cancellations, downgrades) |
(37) |
(18) |
(18) |
(14) |
(31) |
(22) |
(24) |
(26) |
(32) |
End |
414 |
415 |
441 |
461 |
482 |
530 |
561 |
570 |
571 |
Net change |
(28) |
1 |
26 |
20 |
21 |
48 |
31 |
9 |
1 |
OTCQB |
|||||||||
Start |
907 |
893 |
885 |
874 |
902 |
962 |
1,020 |
1,067 |
1,150 |
Additions |
28 |
45 |
62 |
94 |
108 |
112 |
115 |
113 |
113 |
Other (cancellations, downgrades) |
(42) |
(53) |
(73) |
(66) |
(48) |
(54) |
(68) |
(30) |
(39) |
End |
893 |
885 |
874 |
902 |
962 |
1020 |
1067 |
1150 |
1224 |
Net change |
(14) |
(8) |
(11) |
28 |
60 |
58 |
47 |
83 |
74 |
Source: OTCM. Note: Start, end and additions (new sales) figures are reported, while the other figures (cancellations and compliance and other downgrades) are residual.
Our next table summarises the change in operating expenses with commentary on year-on-year changes. Compensation and benefits remain the most significant driver of costs and the increase was driven mainly by cash awards. The current pressure on wages in the United States, especially for IT personnel, has had an impact on compensation and benefits.
Exhibit 3: Analysis of operating expenses
$000s unless stated |
Q121 |
Q122 |
Absolute chg y-o-y |
% chg |
Comments on year-on-year change |
Compensation and benefits |
8,946 |
10,223 |
1,277 |
14.3 |
Headcount up 9 to 112, higher annual base salary increases, stock-based compensation +19% to $185k |
IT Infrastructure and information services |
1,638 |
1,958 |
320 |
19.5 |
Increased spending on third-party information systems and software licences to increase security and improve support systems |
Professional and consulting fees |
1,242 |
1,217 |
(25) |
(2.0) |
Lower regulatory and clearing costs due to lower OTC Link ECN transaction volumes. Blue Sky Data Corp M&A costs offset some of that decline |
Marketing and advertising |
205 |
278 |
73 |
35.6 |
Rebound in travel and event related spending, third-party market research |
Occupancy costs |
613 |
595 |
(18) |
(2.9) |
|
Depreciation and amortisation |
444 |
440 |
(4) |
(0.9) |
|
General, administration and other |
289 |
291 |
2 |
0.7 |
|
Total |
13,377 |
15,002 |
1,625 |
12.1 |
Source: OTC Markets Group, Edison Investment Research
Exhibit 4 shows changes in operating data and related revenue data. Trading volumes fell sharply in the OTCQX both year-on-year (-53%) and quarter-on-quarter (-30%). The Pink segment’s trading was more resilient, down 17% y-o-y but up 6% q-o-q. OTCQB volume fell 82% from an unusually strong Q121 and was down 38% on Q421.
On the other hand, the number of OTC Link ATS participants (90, +10% y-o-y) and ECN subscribers (98, +20% y-o-y) continues to increase.
Corporate Services also showed very strong year on-year increases across the three segments: OTCQX (18%), OTCQB (27%) and Pink (101%). Revenue per client dropped by 2%.
Market Data Licensing saw a 12% year-on-year drop in the total number of users. However, the number of professional users (which generate more revenue) increased by 10%. As we expected, the weak financial markets had a significant impact on the number of non-professional users, which fell by 31%. Revenue per terminal rose by 24%, reflecting this change in user mix.
Exhibit 4: Operating and related revenue data
$000s unless stated |
Q221 |
Q321 |
Q421 |
Q421 |
Q122 |
% change y-o-y |
% change q-o-q |
OTC Link |
|||||||
Dollar volume traded (millions) |
|||||||
OTCQX |
77,599 |
60,030 |
41,802 |
51,331 |
36,168 |
(53) |
(29.5) |
OTCQB |
17,062 |
8,796 |
5,008 |
4,986 |
3,108 |
(82) |
(37.7) |
Pink |
134,063 |
100,644 |
107,295 |
105,231 |
111,078 |
(17) |
5.6 |
Number of securities quoted |
12,091 |
12,725 |
11,604 |
12,011 |
12,071 |
(0) |
0.5 |
Number of active ATS participants |
82 |
83 |
85 |
86 |
90 |
10 |
4.7 |
Number of ECN subscribers |
82 |
84 |
90 |
93 |
98 |
20 |
5.4 |
New Form 211 filings |
197 |
200 |
151 |
96 |
90 |
(54) |
(6.3) |
Revenue per security quoted ($) |
850 |
604 |
527 |
465 |
450 |
(47) |
(3.3) |
Corporate Services |
|||||||
Number of corporate clients (period end) |
|||||||
OTCQX |
482 |
530 |
561 |
570 |
571 |
18 |
0.2 |
OTCQB |
962 |
1,020 |
1,067 |
1,150 |
1,224 |
27 |
6.4 |
Pink |
789 |
999 |
1,556 |
1,563 |
1,584 |
101 |
1.3 |
Total |
2,233 |
2,549 |
3,184 |
3,283 |
3,379 |
51 |
2.9 |
Revenue per client ($) |
3,640 |
3,840 |
3,705 |
3,655 |
3,582 |
(2) |
(2.0) |
Graduates to a national securities exchange |
29 |
46 |
45 |
35 |
24 |
(17) |
(31.4) |
Market Data Licensing |
|||||||
Market data professional users |
24,404 |
25,647 |
25,870 |
26,563 |
26,756 |
10 |
0.7 |
Market data non-professional users |
27,814 |
28,977 |
29,156 |
28,206 |
19,061 |
(31) |
(32.4) |
Revenue per terminal (total - $) |
151 |
157 |
154 |
157 |
187 |
24 |
16.9 |
Market data compliance file users |
46 |
47 |
47 |
49 |
51 |
11 |
4.1 |
Source: OTCM, Edison Investment Research
Blue Sky Data acquisition
Blue Sky Data Corp provides equity and debt compliance data on state ‘blue sky’ securities rules and regulations. The deal enables OTCM to improve its value proposition and expand its subscriber base by allowing OTCM to provide ‘a comprehensive view of Blue-Sky secondary trading compliance data’ that is ‘delivered in an efficient format for broker-dealers, financial advisors, public companies, and regulators’. This will help these subscribers better understand compliance and state securities laws in the US. The deal is expected to bring approximately 30 clients, in addition to the synergies with the market data licensing business.
The purchase price is approximately $12m paid in cash and completed in May 2022. We note that OTCM had a net cash position of $45m (excluding restricted cash) at the end of 1Q22. The company hopes to largely complete the integration of Blue Sky Data by the end of June. A handful of employees are expected to be added to OTCM’s current headcount of 112.
Current trading environment and outlook
US inflation and recession fears have been increasing and this has been resulting in weaker financial markets, including equities. Back in December 2021, the market was pricing a 0.5% Fed Funds target rate at the end of 2022. This had moved to 1.8% when we wrote our last note on OTC two months ago (Q421 was another beat, 2022 is more uncertain) and now the forecasts are for a 2.8% target rate for the end of 2022.
As the Citi US Inflation Surprise Index (Exhibit 6) shows, the market has been underestimating inflation for quite a while. It is clear much of the inflation is transient, driven by supply chain disruptions, consumers spending money saved during the lockdowns and the current war in Ukraine. However, much uncertainty remains regarding how much will be sticky and anchor into wage and inflation expectations.
The degree of the economic slowdown (US GDP growth was already negative in Q122) and the degree to which the Fed will have to apply the brakes to rein in inflation are all weighing on equity markets. Exhibit 7 shows that the pain in equities is broad-based both in larger and smaller companies, although smaller companies (which on average present stronger long-term growth potential as well as higher risk) are usually sold off more during downturns. The technology-heavy Nasdaq index (previously quite highly rated, and now one of the sectors more actively sold) is down 28% over the last six months compared to 16% in the S&P 500.
The cryptocurrency boom has been a major factor in rising volumes in OTC (since crypto-related stocks are among the most traded stocks on OTC markets) and currently cryptocurrencies are also contributing to slowing volumes.
|
Exhibit 5: US Fed Funds rate expectations rising |
Exhibit 6: Citi Inflation Surprise Index – US |
|
|
|
Source: Refinitiv. Note: Expectations based on the overnight swaps. |
Source: Refinitiv |
|
Exhibit 5: US Fed Funds rate expectations rising |
|
|
Source: Refinitiv. Note: Expectations based on the overnight swaps. |
|
Exhibit 6: Citi Inflation Surprise Index – US |
|
|
Source: Refinitiv |
Exhibit 7: Recent market index performance (total return %)
Period |
S&P 500 |
Nasdaq |
OTCQX |
OTCQB |
S&P TSX |
US$ |
US$ |
US$ |
US$ |
C$ |
|
Three months |
-10.1 |
-16.6 |
-4.1 |
-6.6 |
-19.6 |
Six months |
-16.0 |
-28.4 |
-10.7 |
-15.1 |
-29.6 |
One year |
-4.4 |
-14.1 |
-1.3 |
-26.7 |
-26.7 |
Source: Refinitiv. Note: Priced on 19 May 2022.
The State Street Investor Confidence Index tracks changes in institutional investor holdings in risky versus safer investments. Exhibit 8 shows that confidence is higher than during the early stages of the pandemic in 2020. However, clearly the confidence is falling following the boost after Omicron proved to be less dangerous than first feared. With the index below 100, the mood is currently bearish.
|
Exhibit 8: State Street Investor Confidence Index |
|
|
Source: State Street Corporation |
2021 was a record year for IPOs on the Nasdaq, TSX Ventures and TSX exchanges, rising by 138% and 159% on Nasdaq and TSX Ventures respectively and by 12% on TSX. The first quarter saw 84 IPOs in the Nasdaq, which although less than a year ago (135) is still above the long-term average of 59.
|
Exhibit 9: Number of IPOs, Nasdaq |
Exhibit 10: Number of IPOs, TSX and TSX Venture |
|
|
|
Source: Nasdaq |
Source: TMX |
|
Exhibit 9: Number of IPOs, Nasdaq |
|
|
Source: Nasdaq |
|
Exhibit 10: Number of IPOs, TSX and TSX Venture |
|
|
Source: TMX |
Financials
We have slightly increased our revenue forecasts and now estimate that OTCM’s gross revenue will drop by 6% in FY22 (previously we expected a 9% decrease). The driver for this drop remains the same: weaker financial markets and elevated macroeconomic and political uncertainty will lead to lower trading volumes.
The forecast increase in FY23 revenue remains similar (5.5% vs 5.0% previously) but from a slightly higher FY22 forecast. We assume that trading levels normalise and resume an upward trend, but are still factoring in relatively difficult markets in FY23, which may prove to be excessively cautious.
Exhibit 11 shows details of our revenue assumptions. We forecast a 35% decline in revenue from the OTC Link business; this segment accounted for 29% of OTCM’s revenue in FY21 and is most exposed to a drop in trading volumes.
Trading volumes in OTC Link ECN (the key driver in OTC Link’s variable revenue component) are not reported monthly and the pricing structure is complex (variables include the type of investors that are trading, lot sizes, which securities are being traded and even the fact that different share prices have different trading costs). This complicates forecasts beyond the usual challenge in that trading volumes can be quite volatile.
We forecast a 4% decline in revenue from Market Data Licensing. This segment has been proving more resilient to weaker markets, but we would expect to see a decline as some users step back from trading in less favourable market conditions, especially non-professional users, which had been the fastest growing segment. The Blue Sky Data acquisition boosts OTCM’s offering in this segment and could provide potential upside. We do not have guidance on revenue from Blue Sky Data (or reliable historical data), but we have increased Market Data Licencing revenue growth for 2023 from 4% to 6%.
Corporate Services is the most resilient of the three segments as it correlates more with economic activity than trading volume or market performance. We have upped our FY22 growth forecast from 12% to 14% to reflect the good Q122 performance and raised FY23 growth from 4% to 5%.
Exhibit 11: Selected revenue and cost assumptions
$000s unless stated |
2018 |
2019 |
2020 |
2021 |
2022e |
2023e |
Gross revenue |
||||||
OTC Link |
11,175 |
11,676 |
15,890 |
29,665 |
19,377 |
20,540 |
Market Data Licensing |
23,384 |
24,447 |
28,133 |
33,751 |
32,448 |
34,395 |
Corporate Services |
24,719 |
26,716 |
27,206 |
39,516 |
45,068 |
47,321 |
Gross revenues |
59,278 |
62,839 |
71,229 |
102,932 |
96,893 |
102,256 |
% year-on-year |
||||||
OTC Link |
11% |
4% |
36% |
87% |
(35%) |
6% |
Market Data Licensing |
7% |
5% |
15% |
20% |
(4%) |
6% |
Corporate Services |
9% |
8% |
2% |
45% |
14% |
5% |
Gross revenues |
8% |
6% |
13% |
45% |
(6%) |
6% |
Operating expenses (incl. depreciation & amort.) |
||||||
Compensation and benefits |
23,820 |
26,994 |
28,896 |
34,049 |
42,001 |
44,101 |
IT Infrastructure and information services |
5,554 |
6,382 |
6,452 |
7,633 |
7,963 |
8,201 |
Professional and consulting fees |
2,110 |
1,982 |
2,704 |
4,495 |
4,479 |
4,568 |
Marketing and advertising |
1,148 |
1,117 |
807 |
1,028 |
1,062 |
1,105 |
Occupancy costs |
2,107 |
2,548 |
2,303 |
2,348 |
2,424 |
2,473 |
Depreciation and amortisation |
1,042 |
1,492 |
1,761 |
1,796 |
1,819 |
1,855 |
General, administration and other |
1,029 |
1,207 |
1,040 |
1,273 |
1,201 |
1,237 |
Total |
36,810 |
41,722 |
43,963 |
52,622 |
60,948 |
63,540 |
% year-on-year |
||||||
Compensation and benefits |
11% |
13% |
7% |
18% |
23% |
5% |
IT Infrastructure and information services |
(6%) |
15% |
1% |
18% |
4% |
3% |
Professional and consulting fees |
22% |
(6%) |
36% |
66% |
0% |
2% |
Marketing and advertising |
27% |
(3%) |
(28%) |
27% |
3% |
4% |
Occupancy costs |
19% |
21% |
(10%) |
2% |
3% |
2% |
Depreciation and amortization |
(23%) |
43% |
18% |
2% |
1% |
2% |
General, administration and other |
42% |
17% |
(14%) |
22% |
(6%) |
3% |
Total |
9% |
13% |
5% |
20% |
16% |
4% |
Source: OTCM, Edison Investment Research
We have raised OTCM operating expenses to factor in the cost pressure in staff compensation and IT costs (these two items account on average for about 80% of operating expenses). We have also factored in some costs from the Blue Sky Data acquisition. Our forecasts for operating expenses have been raised by 22% in FY22 and FY23, which has an adverse impact on the earnings forecasts.
Exhibit 12 summarises the changes to our forecasts. We cut our EPS forecasts by 19% and 17% for FY22 and FY23 respectively and the DPS by 20%. OTCM does not have fixed dividend pay-out guidance but usually the pay-out is significant (80–126% since 2014). We have assumed 90% and 86% for FY22 and FY23, within the 83–97% range of the last four years. We expect the quarterly dividends (excluding special dividends) to remain at $0.18 in FY22 and FY23.
Despite the $12m Blue Sky Data acquisition, OTCM’s balance sheet remains strong with no debt. We are forecasting a net cash position of $34.7m including restricted cash ($33.2m ex-restricted cash) at the end of FY22 (FY21: $52.0m with restricted cash, $50.4m ex-restricted cash).
Exhibit 12: FY22 and FY23 estimate revisions
Gross revenue ($m) |
PBT ($m) |
Diluted EPS ($) |
Dividend ($) |
|||||||||
Old |
New |
Change (%) |
Old |
New |
Change (%) |
Old |
New |
Change (%) |
Old |
New |
Change (%) |
|
2022e |
93.6 |
96.9 |
3.5 |
35.6 |
28.0 |
-21.2 |
2.29 |
1.86 |
-19.0 |
2.16 |
1.72 |
-20.4 |
2023e |
97.6 |
102.3 |
3.5 |
36.9 |
31.0 |
-21.2 |
2.36 |
1.95 |
-17.3 |
2.16 |
1.72 |
-20.4 |
Source: Edison Investment Research
Valuation
Exhibit 13 compares OTCM’s P/E ratios to those of a range of market information providers and global exchanges. OTCM is trading at an 9% discount on trailing earnings, but at a premium to forward earnings. The premium is deserved due to OTCM’s strong growth track record, balance sheet and relatively high proportion of subscription-based revenues. Furthermore, its ratios are more comparable to the US-based peers with more subscription revenue, such as MSCI and S&P Global.
Exhibit 13: OTCM comparative multiples
P/E ratios (x) |
|||
2021 |
2022e |
2023e |
|
OTCM |
22.1 |
30.1 |
28.6 |
MSCI |
25.4 |
27.0 |
22.8 |
S&P Global |
47.5 |
38.0 |
33.2 |
Euronext |
16.8 |
15.0 |
14.1 |
Hellenic Exchange |
26.4 |
24.7 |
20.6 |
London Stock Exchange |
25.8 |
23.7 |
20.8 |
BMF (Brasil) |
16.1 |
14.8 |
13.9 |
Intercontinental Exchange |
13.8 |
18.4 |
17.0 |
NASDAQ |
21.7 |
19.2 |
17.9 |
Average |
24.2 |
22.6 |
20.0 |
OTCM vs average |
(9%) |
33% |
43% |
Source: Refinitiv, Edison Investment Research. Note: Prices as at 24 May 2022.
The sensitivity of our discounted cash flow valuation to different discount rates and long-term growth assumptions is shown in Exhibit 14 below. The model factors in lower explicit forecasts for FY22–23, together with an assumption of FY24–25 cash flow growth of 12% and a terminal cash flow multiple of 16x. We obtain a valuation range of $42.7–64.4 per share by flexing the discount rate from 7% to 11% and assuming long-term growth (2026–32e) of 3–6%. This compares to the previous range of $42.4–66.3.
Exhibit 14: Discounted cash flow valuation sensitivity ($ per share)
Discount rate (right) |
7% |
8% |
9% |
10% |
11% |
3% |
56.2 |
52.3 |
48.8 |
45.6 |
42.7 |
4% |
58.8 |
54.7 |
51.0 |
47.6 |
44.5 |
5% |
61.5 |
57.2 |
53.2 |
49.6 |
46.4 |
6% |
64.4 |
59.8 |
55.6 |
51.8 |
48.4 |
Source: Edison Investment Research
Exhibit 15: Financial summary
$000s |
2020 |
2021 |
2022e |
2023e |
Year end 31 December |
||||
PROFIT & LOSS |
||||
OTC Link |
15,890 |
29,665 |
19,377 |
20,540 |
Market Data Licensing |
28,133 |
33,751 |
32,448 |
34,395 |
Corporate Services |
27,206 |
39,516 |
45,068 |
47,321 |
Revenue |
71,229 |
102,932 |
96,893 |
102,256 |
Re-distribution fees and rebates |
(2,810) |
(3,021) |
(2,936) |
(3,096) |
Net revenue |
68,419 |
99,911 |
93,957 |
99,160 |
Transaction-based expenses |
(3,022) |
(9,273) |
(5,419) |
(5,751) |
Revenues less transaction-based expenses |
65,397 |
90,638 |
88,538 |
93,409 |
Operating expenses |
(42,202) |
(50,826) |
(59,129) |
(61,685) |
EBITDA |
23,195 |
39,812 |
29,409 |
31,724 |
Depreciation |
(1,761) |
(1,796) |
(1,819) |
(1,855) |
Operating profit |
21,434 |
38,016 |
27,590 |
29,870 |
Net interest |
(27) |
(51) |
446 |
1,100 |
Profit Before Tax |
21,407 |
37,965 |
28,036 |
30,970 |
Tax |
(3,133) |
(7,489) |
(5,296) |
(6,813) |
Profit after tax |
18,274 |
30,476 |
22,740 |
24,156 |
Profit after tax and allocation to RSAs |
17,839 |
29,766 |
22,208 |
23,624 |
Average Number of Shares Outstanding (m) |
11.6 |
11.8 |
12.0 |
12.1 |
EPS - basic (c) |
156.4 |
258.7 |
190.8 |
200.7 |
Fully diluted EPS (c) |
153.4 |
252.0 |
185.6 |
195.2 |
Dividend per share (c) |
125.0 |
216.0 |
172.0 |
172.0 |
EBITDA Margin (%) |
34 |
40 |
31 |
32 |
Operating profit margin (%) |
31 |
38 |
29 |
30 |
BALANCE SHEET |
||||
Cash & cash investments |
33,733 |
50,394 |
33,177 |
40,257 |
Debtors |
6,609 |
7,404 |
8,000 |
8,000 |
Other current assets |
1,763 |
2,153 |
4,764 |
4,764 |
Long term restricted cash |
1,532 |
1,564 |
1,564 |
1,564 |
Intangible assets |
291 |
291 |
291 |
292 |
Property and other long-term assets |
20,882 |
20,449 |
21,928 |
21,011 |
Total assets |
64,810 |
82,255 |
69,724 |
75,888 |
Deferred revenues |
18,765 |
28,432 |
28,200 |
29,610 |
Other current liabilities |
11,232 |
13,332 |
9,170 |
9,170 |
Tax, rent and other long-term liabilities |
15,267 |
15,537 |
17,913 |
17,558 |
Total Liabilities |
45,264 |
57,301 |
55,283 |
56,338 |
Net assets |
19,546 |
24,954 |
26,441 |
19,550 |
NAV per share ($) |
1.67 |
2.11 |
2.23 |
1.65 |
CASH FLOW |
||||
Net cash flow from operating activities |
26,013 |
46,456 |
19,794 |
29,827 |
Capital expenditure, intangible investment |
(1,034) |
(1,395) |
(764) |
(1,300) |
Blue Sky Data acquisition |
(12,000) |
0 |
||
Dividends |
(14,610) |
(25,459) |
(20,018) |
(20,247) |
Purchase of treasury stock |
(3,520) |
(1,522) |
(2,776) |
0 |
Financing / investments |
(1,330) |
(1,419) |
(1,454) |
(1,200) |
Net cash flow |
5,519 |
16,661 |
(17,217) |
7,080 |
Opening net (debt)/cash |
28,217 |
33,733 |
50,394 |
33,177 |
Closing net (debt)/cash |
33,733 |
50,394 |
33,177 |
40,257 |
Cash and restricted cash |
35,297 |
51,958 |
34,741 |
41,821 |
Source: OTCM, Edison Investment Research
|
|
Research: Healthcare
With fresh funding in place and the FDA’s response to a pre-IND application, AlzeCure is evolving into a Phase II company with the initiation of a Phase IIa study with ACD440, a topical TRPV1 antagonist, for pain. This will be the company’s most advanced clinical trial and a significant catalyst. Its most advanced asset in Alzheimer’s disease (AD), ACD856, a novel cognitive enhancer from its NeuroRestore platform, continues to advance through the multiple ascending dose (MAD) part of the Phase I study, with the latest data showing that the compound successfully crosses the blood-brain barrier. Full data from the MAD part should be released in mid-2022. Our updated valuation is SEK1.08bn or SEK21.3 per share (versus SEK22.4 per share previously).